Stay updated on Durvalumab Combo in Resectable NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combo in Resectable NSCLC Clinical Trial page.

Latest updates to the Durvalumab Combo in Resectable NSCLC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe study record history gains a new revision entry for version v3.6.4, superseding the previous v3.6.3.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedA new revision entry v3.6.3 is added to the record history, replacing the previous v3.6.2 entry. This update reflects the latest page version in the history.SummaryDifference0.1%

- Check40 days agoChange DetectedNew revision entry v3.6.2 appears in the study record history, indicating an updated snapshot of the page. The prior entry v3.6.0 is removed from the history list.SummaryDifference0.1%

- Check54 days agoChange DetectedRecord History now shows 'No longer looking for participants,' indicating recruitment has ended for the study. It also records a new revision tag 'Revision: v3.6.0' and removes the prior 'Revision: v3.5.5' entry from the history.SummaryDifference0.3%

- Check61 days agoChange DetectedThe history page now shows a new release identifier Revision: v3.5.5, replacing the previous v3.5.4. This reflects a software update to the ClinicalTrials.gov interface rather than changes to the trial data or displayed content.SummaryDifference0.1%

- Check83 days agoChange DetectedThe record history includes an added Revision: v3.5.4, replacing the prior v3.5.3 in the sequence of revisions.SummaryDifference0.1%

Stay in the know with updates to Durvalumab Combo in Resectable NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo in Resectable NSCLC Clinical Trial page.